257 related articles for article (PubMed ID: 26439947)
1. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
Arena JE; Stoessl AJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.
Kaasinen V; Vahlberg T
Ann Neurol; 2017 Dec; 82(6):873-882. PubMed ID: 29165839
[TBL] [Abstract][Full Text] [Related]
3. [Functional neuroimaging in movement disorders].
Borbély K
Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty.
Felicio AC; Shih MC; Godeiro-Junior C; Andrade LA; Bressan RA; Ferraz HB
Neurologist; 2009 Jan; 15(1):6-16. PubMed ID: 19131852
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease and dopamine transporter neuroimaging: a critical review.
Shih MC; Hoexter MQ; Andrade LA; Bressan RA
Sao Paulo Med J; 2006 May; 124(3):168-75. PubMed ID: 17119698
[TBL] [Abstract][Full Text] [Related]
6. International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.
Tian M; Zuo C; Cahid Civelek A; Carrio I; Watanabe Y; Kang KW; Murakami K; Prior JO; Zhong Y; Dou X; Yu C; Jin C; Zhou R; Liu F; Li X; Lu J; Zhang H; Wang J;
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):434-442. PubMed ID: 37789188
[TBL] [Abstract][Full Text] [Related]
7. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.
Booij J; Knol RJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S425-8. PubMed ID: 18267276
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
de Natale ER; Niccolini F; Wilson H; Politis M
Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
[TBL] [Abstract][Full Text] [Related]
10. The role of SPECT imaging of the dopaminergic system in translational research on Parkinson's disease.
Suwijn SR; de Bruin K; de Bie RM; Booij J
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S184-6. PubMed ID: 24262177
[TBL] [Abstract][Full Text] [Related]
11. Developments in neuroimaging: positron emission tomography.
Stoessl AJ
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S180-3. PubMed ID: 24262176
[TBL] [Abstract][Full Text] [Related]
12. New developments of dopaminergic imaging in Parkinson's disease.
Varrone A; Halldin C
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):68-82. PubMed ID: 22460161
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography in premotor Parkinson's disease.
Stoessl AJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S421-4. PubMed ID: 18267275
[TBL] [Abstract][Full Text] [Related]
14. Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations.
Fu JF; Klyuzhin I; McKenzie J; Neilson N; Shahinfard E; Dinelle K; McKeown MJ; Stoessl AJ; Sossi V
Neuroimage Clin; 2019; 23():101856. PubMed ID: 31091502
[TBL] [Abstract][Full Text] [Related]
15. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in the living brain of Parkinson's disease.
Ouchi Y; Yagi S; Yokokura M; Sakamoto M
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S200-4. PubMed ID: 20082990
[TBL] [Abstract][Full Text] [Related]
17. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
Adams JR; van Netten H; Schulzer M; Mak E; Mckenzie J; Strongosky A; Sossi V; Ruth TJ; Lee CS; Farrer M; Gasser T; Uitti RJ; Calne DB; Wszolek ZK; Stoessl AJ
Brain; 2005 Dec; 128(Pt 12):2777-85. PubMed ID: 16081470
[TBL] [Abstract][Full Text] [Related]
18. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ
Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
[TBL] [Abstract][Full Text] [Related]
19. Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications.
Ikeda K; Ebina J; Kawabe K; Iwasaki Y
Intern Med; 2019 Jun; 58(12):1665-1672. PubMed ID: 30799370
[TBL] [Abstract][Full Text] [Related]
20. [Molecular imaging in Parkinson's disease].
Arahata Y; Kato T; Ito K
Nihon Rinsho; 2007 Feb; 65(2):327-31. PubMed ID: 17302279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
